Recon: Pfizer, BioNTech to request EUA for COVID booster for children 5-11; Merck’s pneumococcal vaccine wins breakthrough designation from FDA
ReconJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesBiotechnologyDiagnostics/IVDsGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy